Health Information and Quality Authority (HIQA), published online April 2019This health technology assessment (HTA) aimed to establish the clinical and cost-effectiveness of CRP POCT, plus examined the organisational implications of the potential introduction of the technology into primary care. A summary of key findings is provided below:
Health Technology Assessment of CRP POCT to guide antibiotic prescribing for acute respiratory tract infections in primary care settings
European Network for Health Technology Assessment (EUnetHTA), published online January 2019This collaborative assessment on C-reactive protein (CRP) point-of-care testing (POCT) aims to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs). The assessment sought to answer three questions by conducting three separate systematic reviews:
C-reactive protein POCT to guide antibiotic prescribing in primary care settings for acute respiratory tract infections
Jan Verbakel, Joseph Lee, Clare Goyder, Pui San Tan, Thanusha Ananthakumar, Philip Turner, Gail Hayward, and Ann Van den BruelBMJ Open, 2019The aim of this review was to collate all available evidence on the impact of C-reactive protein (CRP) point-of-care testing (POCT) on patient-relevant outcomes in children and adults in ambulatory care.
Impact of CRP POC testing in ambulatory care: a systematic review and meta-analysis
Erna Lenters-Westra, and Emma EnglishJournal of Diabetes Science and Technology 2018;12(4):762-770Given the importance of point-of-care testing (POCT) in healthcare delivery, Lenters-Westra and English investigate the quality criteria used to evaluate POCT devices to establish whether these perform to the same standard as main laboratory analysers. They apply the Clinical and Laboratory Standards Institute (CLSI) protocols EP-5 and EP-9 to evalua...
Evaluation of four HbA1c POC devices using international quality targets: are they fit for the purpose?
Emma English, Larissa-Nele Schaffert and Erna Lenters-WestraClinical Laboratory International, November 2018In this article, the authors discuss the benefits of point-of-care testing (POCT), from expediting diagnosis, to ease of monitoring, to cost and time efficiencies in rural and hard-to-reach environments. They go on to explain the different analytical methods for HbA1c measurement, the quality criteria for HbA1c POCT and the quality of POC d...
Point-of-care testing for HbA1c: clinical need and analytical quality
Erna Lenters-Westra and Emma EnglishJournal of Diabetes Science and Technology 2019;13(6):1154-1157Lenters-Westra and English consider the pros and cons of different methods for evaluating the performance of HbA1c point-of-care testing (POCT) devices, including:
Investigating the quality of POCT devices for HbA1c: what are our next steps?
en
지금 액세스
인증된 콘텐츠
Restricted
더 이상 결과 없음
By using this site, you agree with our use of cookies.
